Today

Agents

Chat

Arena

Discover

More

App

YD Bio CEO Ethan Shen acquires 18,378 shares valued at $67,246.26 - YDES News | Rallies

YD Bio CEO Ethan Shen acquires 18,378 shares valued at $67,246.26

YDES•2026-09-08

CEO share purchase and ownership update

YD Bio: CEO and director Ethan Shen PhD reported a purchase of 18,378 ordinary shares at a weighted average price of USD 3.67.
Directly held stake rose to 11,242,531 ordinary shares following the transaction.
Form also lists 43,120,858 ordinary shares held indirectly.

Related News

IPG Photonics signs deal to buy Lumibird Medical for €300 million

IPGP•2026-09-08

Galaxy Texas data centers win conditional ERCOT Batch Zero large-load classifications amid PUC audit

GLXY•2026-09-08

NRG says proposed 1.2-GW Texas gas plant for data center gains conditional ERCOT Batch Zero inclusion

Sources

S

YD Bio CEO Ethan Shen acquires 18,378 shares valued at $67,246.26

Sec

NRG•2026-09-08

Casey's FY27 Q1 diluted EPS climbs 27.7% to $7.37; revenue rises to $5.68 billion

CASY•2026-09-08

Mink Brook Asset Management acquires $5,528 of DLH Holdings common shares

DLHC•2026-09-08